Challenges and reforms in Spain’s health technology assessment system: analysis of criteria influencing medicines’ reimbursement decisions between 2019 and 2022 in Spain
The criteria used to justify the reimbursement decisions of medicines in Spain do not align with the information included in the HTA. This discrepancy highlights the need for the ongoing HTA reform to develop an appraisal framework that aligns with the HTA assessment in a transparent, rigorous, and inclusive manner.
Authors
- Pilar Pinilla‐Dominguez (ORCID: https://orcid.org/0000-0001-6978-9343)
- Jaime Pinilla (ORCID: https://orcid.org/0000-0002-7126-4236)
Institutions
- Universidad de Las Palmas de Gran Canaria (ES)
- National Institute for Health and Care Excellence (GB)
Publication Details
- Journal
- The European Journal of Health Economics
- Published
- 2025-05-09
- DOI
- https://doi.org/10.1007/s10198-025-01790-7
- Citations
- 2
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 6.26
Funders
- Universidad de Las Palmas de Gran Canaria